Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MSLE will decline by -0.96% over the next 2 Weeks and hit $5.57 by Friday, June 19, 2026. In that time frame, MSLE's share price is expected to range between $5.09 and $6.12.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 19, 2026 | 5.09 | 5.57 | 6.12 |
| Jun 18, 2026 | 4.94 | 5.48 | 6.01 |
| Jun 17, 2026 | 4.89 | 5.39 | 5.89 |
| Jun 16, 2026 | 4.89 | 5.41 | 5.92 |
| Jun 15, 2026 | 5.00 | 5.52 | 6.07 |
| Jun 12, 2026 | 5.21 | 5.71 | 6.26 |
| Jun 11, 2026 | 5.12 | 5.62 | 6.14 |
| Jun 10, 2026 | 5.02 | 5.54 | 6.02 |
| Jun 9, 2026 | 5.05 | 5.56 | 6.04 |
| Jun 8, 2026 | 5.12 | 5.67 | 6.19 |
MSLE shares fell -6.49% in Friday, June 5, 2026's trading session, dropping from a previous close of $6.01 to move at $5.62. The stock demonstrated notable intraday movement (see MSLE's key stats for a full breakdown), fluctuating between $5.62 and $6.18, a +9.96% trading range. While recent weeks have seen some volatility, MSLE has managed to secure a -21.29% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 36.87K shares changing hands, 16.39K fewer than the previous session. This amounted to $207.20K in total market activity.
Will MSLE Continue Its Upward Trend?
According to analyst ratings and projections for MSLE, Satellos Bioscience Inc. Common Stock shares are anticipated to increase by +8.17%, potentially reaching $6.12 per share by June 19, 2026. Short-term technical indicators currently suggest a neutral sentiment for MSLE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the MSLE stock forecast, now is a good time to buy MSLE stock because its current trading price is +0.97% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MSLE covering social and institutional perspectives.
MSLE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MSLE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 26.19% to 37.53%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 46.01%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.13%, maintains a neutral outlook for the long term. Insights into MSLE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Satellos Bioscience Common Stock Short-Term Forecasts
MSLE Forecast For Next 5 Days
Our algorithm anticipates Satellos Bioscience Common Stock (MSLE) stock could hit $5.72 by Jun 12, 2026. This represents a +1.82% fall from today's price, following a - change over the past five days.
MSLE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Satellos Bioscience Inc. Common Stock (MSLE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $5.61, which would mean a -0.18% decrease from the current price of $5.62. Projections for this period range from a high of $7.80 to a low of $3.03.
MSLE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Satellos Bioscience Common Stock's price over the next three months point to a rise. MSLE stock is expected to peak at $15.36 on Jun 19, 2026 before potentially dipping to $3.17 on Sep 04, 2026. On average, MSLE is likely to trade around $7.88 in the coming 90 days.
Satellos Bioscience Common Stock Stock Forecast 2025
Based on our predictive models, Satellos Bioscience Common Stock (MSLE) is expected to trade between $0.38 and $15.36 throughout 2026. This would result in an average price of $4.33, potentially offering investors a -22.95% return from current levels.
Satellos Bioscience Inc. Common Stock Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Satellos Bioscience Inc. Common Stock (MSLE) is positioned to show a strong performance in June 2026. The price is predicted to move between $7.65 and $15.36, settling at an average of $11.30. This could translate to a +101.07% gain.
July 2026
Based on current market signals, Satellos Bioscience Inc. Common Stock is projected to trend july 2026. We forecast a trading range from $6.94 to $10.76, with a likely average price of $8.62. Investors could expect a potential return of +53.38%.
August 2026
Our predictive algorithms indicate Satellos Bioscience Inc. Common Stock stock may see a shift in August 2026. The expected range spans $3.48–$7.43, with an average target of $5.18. This represents a cautious outlook and a possible loss of -7.83%.
September 2026
Analyzing established trends, Satellos Bioscience Inc. Common Stock looks set to move in September 2026. Projections place the stock between $2.50 and $3.61, averaging around $3.10. This suggests a -44.84% loss from current levels.
October 2026
Market indicators suggest Satellos Bioscience Inc. Common Stock could experience notable changes during October 2026. Prices could fluctuate within $1.54 to $2.68, with a midpoint forecast of $1.95. The stock might deliver a -65.30% loss.
November 2026
Forecasting for November 2026, models estimate that Satellos Bioscience Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.53 and $1.44, averaging $0.99. This signals a cautious trajectory with potential returns around -82.38%.
December 2026
According to our latest forecast models, Satellos Bioscience Inc. Common Stock (MSLE) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.38 and $0.89, settling at an average of $0.61. This could translate to a -89.15% loss.
January 2027
Based on current market signals, Satellos Bioscience Inc. Common Stock is projected to trend january 2027. We forecast a trading range from $0.10 to $0.58, with a likely average price of $0.31. Investors could expect a potential return of -94.48%.
February 2027
Our predictive algorithms indicate Satellos Bioscience Inc. Common Stock stock may see a shift in February 2027. The expected range spans $0.06–$0.30, with an average target of $0.17. This represents a cautious outlook and a possible loss of -96.98%.
March 2027
Analyzing established trends, Satellos Bioscience Inc. Common Stock looks set to move in March 2027. Projections place the stock between $0.00 and $0.27, averaging around $0.11. This suggests a -98.04% loss from current levels.
April 2027
Market indicators suggest Satellos Bioscience Inc. Common Stock could experience notable changes during April 2027. Prices could fluctuate within $0.00 to $0.17, with a midpoint forecast of $0.05. The stock might deliver a -99.11% loss.
May 2027
Forecasting for May 2027, models estimate that Satellos Bioscience Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.15, averaging $0.04. This signals a cautious trajectory with potential returns around -99.29%.
June 2027
According to our latest forecast models, Satellos Bioscience Inc. Common Stock (MSLE) is positioned to show a strong performance in June 2027. The price is predicted to move between $0.00 and $0.12, settling at an average of $0.02. This could translate to a -99.64% loss.
MSLE's history of dividends and stock splits also plays a role in long-term investor confidence.